Skip to content

    Recently Viewed

      Listening...

      Janssen

      See all stories about Janssen, a pharmaceutical company of Johnson & Johnson
      Latest news
       Biomedical scientist Robert Langer headshot

      Biomedical scientist Robert Langer receives the 2023 Dr. Paul Janssen Award for Biomedical Research

      Each year, Johnson & Johnson honors a scientist currently working in academia, industry or a scientific institute who has made a significant contribution toward the improvement of public health.
      Latest News
      Black female scientist holding a conical flask filled with yellow liquid

      Johnson & Johnson named a 2024 Fortune World’s Most Admired Company

      The company makes the list for the 22nd year in a row, thanks to its dedication to innovation, social responsibility and more.
      Health & wellness
       Blue latex gloved hand pointing at a brain MRI scan to pinpoint brain circuits associated with depression symptoms

      Is this the end of one-size-fits-all treatments for depression?

      Johnson & Johnson is working to bring personalized psychiatry to the 7 in 10 people with depression whose treatments aren’t getting the job done.
      Health & wellness
      Health worker participating in the Johnson and Johnson single-use device recycling program

      3 ways Johnson & Johnson is helping make healthcare more sustainable

      Climate change is intertwined with just about every industry worldwide, including healthcare. Here, a look at how Johnson & Johnson is taking action to help support a healthy planet.
      Innovation
      DNA illustration genetic material

      Harnessing the human genome is the future of healthcare—and Johnson & Johnson is helping lead the way

      The company’s partnership with the largest human genome sequencing project in the world will increase scientists’ understanding of genetic diseases and help create new interventions. Here, a look at the breakthroughs that have guided the understanding of the power of DNA.
      Health & wellness
      A newborn baby's feet with a hospital bracelet around its ankle

      What it’s like when your baby has a rare blood disorder

      A condition called fetal and neonatal alloimmune thrombocytopenia (FNAIT) can be deadly in newborns. That’s why Johnson & Johnson is passionate about developing a treatment for the disorder.
      Latest news
      A cartoon displaying multiple different types of charts and graphs

      What you need to know about Johnson & Johnson’s 2023 third-quarter earnings

      Check out this infographic breakdown of the company’s third-quarter 2023 performance, with key highlights from its Innovative Medicine and MedTech businesses.
      Innovation
      Researcher using a pipette in the lab

      Behind the relentless pursuit of multiple myeloma cures

      Johnson & Johnson has been dedicated to developing innovative treatments for blood cancers for nearly 20 years. Scientist Kodandaram “Ram” Pillarisetti is at the forefront of the company’s commitment to working toward its goal of one day eliminating the disease.
      Latest news
      What-You-Need-to-Know-About-Johnson-and-Johnsons-2023-Second-Quarter-Earnings-0723.jpg

      What you need to know about Johnson & Johnson’s 2023 second-quarter earnings

      Check out this infographic breakdown of the company’s second-quarter 2023 performance, with key highlights from its Pharmaceutical, MedTech and Consumer Health businesses.